In this issue:
Risankizumab vs adalimumab for plaque psoriasis
Non-biologic systemic therapies for psoriasis
Topology of psoriasis in routine care
Users of biologics in clinical practice
Biologic therapies targeting IL-23/IL-17
Tildrakizumab for moderate-tosevere plaque psoriasis
Pioglitazone + phototherapy in plaque psoriasis
Pioglitazone for treatment of plaque psoriasis
Special aspects of biologic treatment in psoriasis
Review: TNF and IL-17 inhibitors in psoriasis
Smoking and response to systemic anti-psoriatic therapies
Please login below to download this issue (PDF)